Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Radius Health (RDUS)

Radius Health (RDUS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 886,297
  • Shares Outstanding, K 46,894
  • Annual Sales, $ 238,650 K
  • Annual Income, $ -109,210 K
  • 60-Month Beta 0.94
  • Price/Sales 3.87
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade RDUS with:

Options Overview

Details
  • Implied Volatility 96.26%
  • Historical Volatility 47.28%
  • IV Percentile 97%
  • IV Rank 81.60%
  • IV High 108.55% on 01/27/21
  • IV Low 41.77% on 11/12/20
  • Put/Call Vol Ratio 0.20
  • Today's Volume 6
  • Volume Avg (30-Day) 158
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 4,491
  • Open Int (30-Day) 3,108

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.41
  • Number of Estimates 4
  • High Estimate -0.34
  • Low Estimate -0.52
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +49.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.37 +4.14%
on 04/20/21
26.16 -26.87%
on 03/23/21
-3.35 (-14.90%)
since 03/19/21
3-Month
17.63 +8.51%
on 02/23/21
26.16 -26.87%
on 03/23/21
-2.53 (-11.68%)
since 01/20/21
52-Week
10.15 +88.45%
on 09/28/20
26.16 -26.87%
on 03/23/21
+3.62 (+23.34%)
since 04/20/20

Most Recent Stories

More News
Radius Health to Announce First Quarter 2021 Financial Results, Host Conference Call and Live Webcast on Friday, May 7, 2021

Radius Health (Nasdaq: RDUS) announced today that it will release its first quarter financial results on Friday, May 7, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m....

RDUS : 19.13 (+1.22%)
Radius Health (RDUS) Up 14.7% Since Last Earnings Report: Can It Continue?

Radius Health (RDUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

RDUS : 19.13 (+1.22%)
Radius Health Provides Update on Abaloparatide

Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS) provided an update on the abaloparatide asset including regulatory progress as well as U.S. commercial activity.

RDUS : 19.13 (+1.22%)
Radius Health (RDUS) Soars 14.6%: Is Further Upside Left in the Stock?

Radius Health (RDUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength...

RDUS : 19.13 (+1.22%)
Radius Health Reaches Analyst Target Price

In recent trading, shares of Radius Health Inc have crossed above the average analyst 12-month target price of $23.29, changing hands for $25.77/share. When a stock reaches the target an analyst has...

RDUS : 19.13 (+1.22%)
NASDAQ Drops Another 2.7% as Bond Yields Rise Again

NASDAQ Drops Another 2.7% as Bond Yields Rise Again

SAIL : 48.01 (+0.71%)
MMSI : 60.95 (-0.02%)
RDUS : 19.13 (+1.22%)
TTD : 686.07 (-1.35%)
BJ : 44.04 (-0.88%)
NVAX : 208.15 (-6.03%)
PRIM : 33.36 (-2.88%)
CAR : 74.71 (-4.40%)
MNKD : 4.23 (+1.68%)
ZUMZ : 42.36 (-4.42%)
TVTX : 25.22 (+1.61%)
GH : 149.47 (-2.26%)
VXRT : 5.06 (-0.98%)
QDEL : 119.51 (-2.30%)
PLAN : 57.67 (-1.18%)
NFLX : 549.57 (-0.88%)
AAPL : 133.11 (-1.28%)
AMZN : 3,334.69 (-1.11%)
GOOG : 2,293.63 (-0.38%)
FB : 302.65 (+0.14%)
MSFT : 258.26 (-0.19%)
Radius Health, Inc. Announces $175 Million Financing Transaction

Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS), today announced that the Company has entered into amended and restated credit facilities in the aggregate principal amount of $175 million,...

RDUS : 19.13 (+1.22%)
KemPharm (KMPH) Soars on FDA Nod for ADHD Treatment, Azstarys

The FDA approves KemPharm's (KMPH) NDA for Azstarys for the treatment of attention deficit hyperactivity disorder in patients aged six years and older. Shares rise.

CANF : 2.18 (+4.81%)
RDUS : 19.13 (+1.22%)
KMPH : 8.97 (+3.22%)
OPHLF : 25.0500 (unch)
ChemoCentryx (CCXI) Q4 Loss Wider Than Expected, Sales Miss

ChemoCentryx Inc. (CCXI) reports a wider-than-expected loss in the fourth quarter and misses on sales.

ZTS : 168.74 (+0.38%)
CCXI : 45.29 (+1.09%)
RDUS : 19.13 (+1.22%)
SAVA : 32.15 (-5.41%)
Radius' (RDUS) Q4 Loss Wider Than Expected, Revenues Beat

Radius (RDUS) reports a wider loss but beats sales estimates in the fourth quarter.

ENDP : 5.63 (-4.41%)
LLY : 190.61 (+0.51%)
AMGN : 259.14 (+1.24%)
RDUS : 19.13 (+1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Radius Health Inc. is a science-driven biopharmaceutical company. It is focused on developing novel differentiated therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases. The Company's lead product candidate, abaloparatide (BA058), is in development, in both...

See More

Key Turning Points

3rd Resistance Point 20.24
2nd Resistance Point 19.72
1st Resistance Point 19.42
Last Price 19.13
1st Support Level 18.60
2nd Support Level 18.08
3rd Support Level 17.78

See More

52-Week High 26.16
Fibonacci 61.8% 20.04
Last Price 19.13
Fibonacci 50% 18.16
Fibonacci 38.2% 16.27
52-Week Low 10.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar